114 related articles for article (PubMed ID: 27941203)
1. [Diagnosis and therapy of steroid-induced hyperglycemia based on literature reports].
Dąbrowski P; Majdan M
Wiad Lek; 2016; 69(4):642-645. PubMed ID: 27941203
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycemia and Diabetes Induced by Glucocorticoids in Nondiabetic and Diabetic Patients: Revision of Literature and Personal Considerations.
Elena C; Chiara M; Angelica B; Chiara MA; Laura N; Chiara C; Claudio C; Antonella F; Nicola G
Curr Pharm Biotechnol; 2018; 19(15):1210-1220. PubMed ID: 30605054
[TBL] [Abstract][Full Text] [Related]
3. Glucose tolerance disorders during treatment with glucocorticoids in patients with inflammatory diseases of the musculoskeletal system - based on the analysis of data from the literature and own research results.
Dąbrowski P; Majdan M
Postepy Hig Med Dosw (Online); 2017 May; 71(0):307-314. PubMed ID: 28513455
[TBL] [Abstract][Full Text] [Related]
4. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
5. How should rheumatologists manage glucocorticoid-induced hyperglycemia?
Nakamura H; Fujieda Y; Nakamura A; Atsumi T
Mod Rheumatol; 2021 May; 31(3):519-528. PubMed ID: 32921205
[TBL] [Abstract][Full Text] [Related]
6. Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm.
Wintergerst KA; Deiss D; Buckingham B; Cantwell M; Kache S; Agarwal S; Wilson DM; Steil G
Diabetes Technol Ther; 2007 Jun; 9(3):211-22. PubMed ID: 17561791
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced hyperglycemia.
Kwon S; Hermayer KL; Hermayer K
Am J Med Sci; 2013 Apr; 345(4):274-277. PubMed ID: 23531958
[TBL] [Abstract][Full Text] [Related]
8. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
Shaefer CF; Anderson J
Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
[TBL] [Abstract][Full Text] [Related]
9. The incretin effect in critically ill patients: a case-control study.
Nielsen ST; Janum S; Krogh-Madsen R; Solomon TP; Møller K
Crit Care; 2015 Nov; 19():402. PubMed ID: 26567860
[TBL] [Abstract][Full Text] [Related]
10. Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy.
Rowbottom L; Stinson J; McDonald R; Emmenegger U; Cheng S; Lowe J; Giotis A; Cheon P; Chow R; Pasetka M; Thavarajah N; Pulenzas N; Chow E; DeAngelis C
Ann Palliat Med; 2015 Apr; 4(2):70-7. PubMed ID: 25971294
[TBL] [Abstract][Full Text] [Related]
11. [Steroid-induced hyperglycemia, a common clinical problem in medicine without evidence-based guidelines].
Genolet P; Petite C; Petignat PA
Rev Med Suisse; 2012 Apr; 8(336):800-2, 804-5. PubMed ID: 22574414
[TBL] [Abstract][Full Text] [Related]
12. Inpatient glucocorticoid use: beneficence vs non-maleficence.
Dhatariya K
Br J Hosp Med (Lond); 2014 May; 75(5):252-6. PubMed ID: 25040268
[No Abstract] [Full Text] [Related]
13. Efficacy of a basal bolus insulin protocol to treat prednisolone-induced hyperglycaemia in hospitalised patients.
Burt MG; Drake SM; Aguilar-Loza NR; Esterman A; Stranks SN; Roberts GW
Intern Med J; 2015 Mar; 45(3):261-6. PubMed ID: 25565560
[TBL] [Abstract][Full Text] [Related]
14. Managing type 2 diabetes: going beyond glycemic control.
Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
[TBL] [Abstract][Full Text] [Related]
15. [Glucocorticoid-induced insulin resistance and diabetes mellitus. Receptor-, postreceptor mechanisms, local cortisol action, and new aspects of antidiabetic therapy].
Meyer G; Badenhoop K
Med Klin (Munich); 2003 Apr; 98(5):266-70. PubMed ID: 12721671
[TBL] [Abstract][Full Text] [Related]
16. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-induced hyperglycemia.
Clore JN; Thurby-Hay L
Endocr Pract; 2009; 15(5):469-74. PubMed ID: 19454391
[TBL] [Abstract][Full Text] [Related]
18. [Metformin has a positive effect on disorders of carbohydrate metabolism in long-term care with low doses of prednisone].
Vondra K; Nĕmcová D; Stárka L; Bílek R; Bendlová B; Hampl R; Hill M; Hoza J; Kot'átková A; Vrbíková J; Zamrazil V
Cas Lek Cesk; 2002 Apr; 141(8):255-60. PubMed ID: 12038076
[TBL] [Abstract][Full Text] [Related]
19. Constitutive increase in active GLP-1 levels by the DPP4 inhibitor ASP4000 on a new meal tolerance test in Zucker fatty rats.
Tanaka-Amino K; Hatakeyama Y; Takakura S; Mutoh S
Pharmacol Res; 2009 Oct; 60(4):264-9. PubMed ID: 19520592
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
